Hidroferol® ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
113Muscular dystrophy1

113. Muscular dystrophy


Clinical trials : 622 Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-005808-41-ES
(EUCTR)
25/02/200825/01/2008Estudio multicéntrico para comprobar la respuesta clínico-analítica de pacientes portadores sintomáticos de Disferlinopatía al tratamiento con CalcifediolMulticentric study to assess the clinical and analytical response to calcifediol in symptomatic carriers of dysferlin myopathyEstudio multicéntrico para comprobar la respuesta clínico-analítica de pacientes portadores sintomáticos de Disferlinopatía al tratamiento con CalcifediolMulticentric study to assess the clinical and analytical response to calcifediol in symptomatic carriers of dysferlin myopathy Portadores sintomaticos de una mutación en el gen disferlina.Symptomatic carriers of a mutation in the dysferlin gene
MedDRA version: 9.1;Level: LLT;Classification code 10028356;Term: Muscular dystrophy
Trade Name: Hidroferol®
Product Name: Calcifediol
INN or Proposed INN: CALCIFEDIOL
Other descriptive name: HIDROFEROL
Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Spain